Analyst Gary Nachman works at BMO and is focused on the Healthcare sector with 475 price targets and ratings documented since 2013 spanning on 24 stocks. Analyst's average stock valuation to be materialised ratio is 42.02% with an average time for price targets to be met of 135.96 days.
Most recent stock forecast was given on SAGE, Sage Therapeutics, Inc at 09-Nov-2022.
Gary Nachman best performing recommendations are on LCI (LANNETT COMPANY, INC).
The best stock recommendation documented was for MNK at 9/5/2019. The price target of $3 was fulfilled within 5 days with a profit of $1.41 (88.68%) receiving and performance score of 177.36.
Average potential price target upside